Evidence map›Paper›PMID 30607175›Full record

ArticleBiotechnology for biofuels2018

Discovery of novel geranylgeranyl reductases and characterization of their substrate promiscuity.

Corey W Meadows, Florence Mingardon, Brett M Garabedian, Edward E K Baidoo, Veronica T Benites, Andria V Rodrigues, Raya Abourjeily, Angelique Chanal, Taek Soon Lee

Open access · goldAbstract read
In one paragraph

Article in Biotechnology for biofuels, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Presence of Phylloquinone in the Intraerythrocytic Stages ofFrontiers in cellular and infection microbiology · 2022
    Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Corey W Meadows *1Joint BioEnergy Institute, 5885 Hollis Street, 4th floor, Emeryville, CA 94608 USA.
Florence Mingardon *Total Raffinage Chimie, 2 Pl. Jean Millier, 92400 Courbevoie, France.
Brett M Garabedian1Joint BioEnergy Institute, 5885 Hollis Street, 4th floor, Emeryville, CA 94608 USA.
Edward E K Baidoo1Joint BioEnergy Institute, 5885 Hollis Street, 4th floor, Emeryville, CA 94608 USA.
Veronica T Benites1Joint BioEnergy Institute, 5885 Hollis Street, 4th floor, Emeryville, CA 94608 USA.
Andria V Rodrigues1Joint BioEnergy Institute, 5885 Hollis Street, 4th floor, Emeryville, CA 94608 USA.
Raya AbourjeilyTotal Raffinage Chimie, 2 Pl. Jean Millier, 92400 Courbevoie, France.
Angelique ChanalTotal Raffinage Chimie, 2 Pl. Jean Millier, 92400 Courbevoie, France.
Taek Soon Lee1Joint BioEnergy Institute, 5885 Hollis Street, 4th floor, Emeryville, CA 94608 USA.ORCID 0000-0002-0764-2626
Lawrence Berkeley National Laboratory · USTotal (France) · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGeranylgeranyl reductase (GGR) is a flavin-containing redox enzyme that hydrogenates a variety of unactivated polyprenyl substrates, which are further processed mostly for lipid biosynthesis in archaea or chlorophyll biosynthesis in plants. To date, only a few GGR genes have been confirmed to reduce polyprenyl substrates in vitro or in vivo.

resultsIn this work, we aimed to expand the confirmed GGR activity space by searching for novel genes that function under amenable conditions for microbial mesophilic growth in conventional hosts such as

conclusionThese collective results enhance the potential for metabolic engineers to manufacture a variety of isoprenoid-based biofuels, polymers, and chemical feedstocks in common microbial hosts such as

Indexed as

Geranylgeranyl reductaseHydrogenationIsoprenoidsRedox enzymesTerpene biosynthesis

Identifiers

PMID30607175
PMCPMC6309074
OpenAlexW2907288229

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.